Findings to inform treatments for those with severe symptoms & Long COVID
Ulster University, Dell Technologies and Seagate have combined their research and data storage capabilities in a collaboration which will allow advanced analyses of COVID-19 patient data.
The Ulster University research team will examine large volumes of medical datasets to establish if there are links between COVID-19, genetic make-up and the severity of the disease. The findings will also inform decisions around drug treatments for those with severe symptoms and possibly Long COVID, as well as providing an insight into how genes may influence vaccination efficiency.
Data storage company, Seagate, and multinational IT company Dell Technologies have delivered the infrastructure required to store patient information for this major research project at the Northern Ireland Centre for Stratified Medicine based at C-TRIC on the Altnagelvin hospital campus.
Seagate donated 100 x 12TB Hard drives and Dell Technologies donated critical equipment and expertise to help deliver a complete solution.
The collaborative partnership is part of the Data4Good initiative aimed at data usage for the benefit of humanity. It created a petabyte of data which is the equivalent of over 1000 large home computers working together or the capability for an individual to store 4,000 digital photographs every day for their lifetime.
Professor of Genomics, Tony Bjourson, Director of the Northern Ireland Centre for Stratified Medicine at C-TRIC at Altnagelvin, and the Project Lead on the UU THRIVE City Deal project said: “We are delighted this crucial infrastructure is now set up, thanks to Seagate and Dell Technologies as without this data storage and IT capacity we could not undertake this work. We recently completed the recruitment of the 500 Covid19 patients for whole genome sequencing. It means reading the sequencing of the 3.2 billion chemical letters that make up each of our genomes. This generates huge amounts of raw data that has to be stored to allow very advanced computational genomic analyses.
“This collaboration, which came about when Seagate and Dell Technologies responded to our call for assistance, offers a good example of how research transforms lives and how technology acts as a catalyst for innovation. We will pursue more of these kind of collaborations through the Derry and Strabane City Deal in the years ahead through data analytics via CARL and health innovation via THRIVE and of course industry partnerships such as this one will be key. For now, as our work during COVID-19 continues, we are so grateful to partners such as Seagate and Dell Technologies for coming together in this way.”
Jason Ward, Vice-President and Managing Director, Dell Technologies Ireland said: “We’re proud to build on our strong partnership with Ulster University through technology and expertise to help their researchers unlock insights into COVID-19 and uncover treatment options for those impacted by the virus. With the latest Dell Technologies storage systems and back-end infrastructure, the team at Ulster University will have immediate access to the data and applications needed to drive their research forward.”
Fergus O’Donnell, Plant Manager and Site Lead at Seagate said: “This collaboration involved a huge effort from the teams at Seagate, Dell Technologies and Ulster University working together to overcome the many logistical and organisational arrangements to help deliver a complete solution. It is important to support these advanced analytics capabilities which enable progress in this vital area of research and bring benefits for local and global communities”.